Customized Study Designs
"When clients’ interests emphasized foremost, they assist leading the approach towards amazing outcomes."
We have completed more than 200 clinical and preclinical studies in compliance with international regulations. We are among the few GCP-compliant CROs that are fully aligned with the FDA and FTC standards for human studies. Perfect single window virtual support anytime everywhere to get physical documentations and strategy to establish the safety & efficacy. We do not just consider contrarily about your project, we feel differently about it, also. When you face the multifaceted glitches involved in changing a scientific unearthing into a new treatment, then accomplishing that management in the hands of patients, you prerequisite people who are devoted at every level. People who hold onto solving, improving, optimizing, and caring just as considerably as you do. No matter how time-consuming, no matter the hindrances.
.......From Planning to Prompt Product Development
Make sure you know where you're heading...
It takes a long time to get a drug from discovery to new treatment. However, the trip is fraught with difficulties and stumbling blocks. We understand that achieving your goal requires extensive knowledge, strategy, and dedication. That's why we'll walk you through the entire procedure step by step, so you can begin with confidence rather than fear. That is why our team of dedicated professionals is unwavering in their approach, addressing the beginning and last phases equally. Above all, it's why we're here: to support you as you develop your innovative therapy while also advancing modern medicine.
You receive a stronger, smarter solution because we interact early...
Our Regulatory & Access advisors are informed of potential stumbling obstacles and cultivate productive, constructive partnerships that support your development programme. That includes everything from pre-IND submission to local market approval, market access, and product lifecycle management. Assisting you in making a compelling case for your product's potential, backed up by proof of safety, efficacy, and value by interacting early with key stakeholders — regulators, payers, physicians, and patients.
Together with you from all points of translational advancement...
Our Early Product Development team matches significant reach with human attention. We can provide data-supported solutions that are flexible enough to meet your scientific and regulatory needs through Phase II. Healthcare operations teams dedicated to all facets of early clinical intervention and site management (safety, labs, monitoring, technical training, cohort review, and recruitment screening). Adaptive designs and multi-stage dose escalation protocols enable operational versatility. Integrated planning and management to take programs from IND through Proof-of-Concept under a single contract Clinical operations, project management, clinical supervision, feasibility, start-up, and a Phase I-II site network are all covered by special clinical SOPs.
Pre-Clinical Studies
Preclinical studies are conducted in in vitro, in vivo, ex vivo, and in silico models to obtain basic information about a drug candidate's safety and biological efficacy prior to testing it in the final target population, i.e., humans. To ensure the reliability and reproducibility of results, preclinical studies or tests are mostly carried out in accordance with GLP/GSP guidelines (good laboratory practise and good scientific practises). The specifics of each preclinical development package may differ, but they all share some characteristics. To define the pharmacokinetic profile and general safety, as well as to identify toxicity patterns, rodent and nonrodent mammalian models are used. The mean residence time of a drug in the body, which is determined by inherent absorption, distribution, metabolism, and excretion properties, can be determined by one or more species. Toxicology and safety studies identify potential organ targets for adverse effects and define the Therapeutic Index, which is used to determine the initial starting doses in clinical trials. Regulatory oversight is generally required for pivotal preclinical safety studies, as defined by Good Laboratory Practices and international guidelines, such as the International Conference on Harmonisation. Concurrent preclinical development activities include the creation of the Clinical Plan and the preparation of the new drug product, including all associated documentation, to meet stringent Good Manufacturing Practices regulatory guidelines.
Early Phase Services
Clinical Pharmacology:
Enhance your clinical success chances.
Clinical pharmacology is integrated in our approach to clinical growth, minimising the time and expense of bringing medicines to market by predicting a drug's benefits and adverse effects in a patient population prior to initiating a clinical trial or clinical study, minimising the patient burden for the drug development journey by using models for analysis of the relationship between medications, illness, and patients. Clinical development model can be used to increase productivity by providing quantitative rationale for clinical trial design, dosage selection, and drug-drug interaction risk evaluation during clinical testing and trial execution. Furthermore, the use of quantitative clinical trials in pharmacology during the lifecycle of a drug candidate aids in the development of high-quality regulatory packages, which aid in regulatory approval. Our experienced pharmacologists will work to extend and optimise the benefit of each patient's exposure and reaction data using both industry standard and proprietary research tools long before your medication is used to treat patients at the bedside. Med Pharma CRO’s Clinical Pharmacology scientists collaborate with the drug development team from start to finish to help prepare and conduct your drug development journey, always keeping patients in mind.
With Med Pharma CRO's expertise, the road to smarter drug production is evident.
The Clinical Pharmacology group at Med Pharma CRO specialises in the strategic application of solutions to assist clients in making better patient-driven drug development decisions that lead to a faster time to market. Our clinical experience spans a wide range of therapeutic fields.
Augment clinical trials through clinical trial simulations.
• Strategic application of model-informed drug development
• Regulatory submissions & labelling to make sure compliance with protocols at all levels
• Bioidentical and bio-better development strategies to assess the safety of drugs
• Analysis for safety and efficacy
• Dose and dosing regimen selection
• Disease & placebo models
• Clinical studies and trial simulation
Bioequivalence Studies:
Creating bioequivalence in a responsible way.
The market for generic pharmaceuticals remains constant in the ever-changing world of drug production and approval. That's why we developed a Bioequivalence Solutions Platform to assist you in determining bioequivalence and then guiding you through the business application process. We can improve on your resources or help you through the entire journey to generic acceptance, no matter how big or small your company is. We understand the complexities of bringing generics to market, and we have the therapeutic expertise and tools to help you get there on time and on budget.
Experience of bioequivalence in patient populations.
Finding the right people to volunteer is one of the most difficult aspects of any development project. Our network enables us to reach out to a wide range of patient groups and ensure that they have a healthy and knowledgeable experience participating in your bioequivalence research. In addition, we have multiple units that specialise in in-patient care to ensure that their needs are met.
Phase I (First in Humans):
With you from inception to new drug — and every point in between.
A clinical trial's early stages might be tense. As a result, finding a partner to experience this crucial stage of your drug's journey is crucial. Working with us will provide you with a more focused and simple approach to initial stage testing. Phase I is when a medicine is tried in humans for the first time, and it usually involves a small number of healthy volunteers. Our staff will conduct testing to determine dosage, side effects, and other safety precautions so that your drug can progress to the next phase safely. We're attempting to figure out how the drug interacts with the body, if there are any negative effects, and if the medicine is safe to use at this point. But the most crucial thing we can offer at this point is an experienced staff who understands the work, technology, and hope you've put into your project so far and is dedicated to moving it forward.
Phase II (Proof of Concept):
We'll put you in touch with the appropriate individuals to help you advance faster.
The appropriate data will show regulators and investors that your novel chemical is effective and ready to move forward at this point. As a result, having access to targeted assistance is crucial to collecting useful data. Phase II is occasionally subdivided into Phase IIa and Phase IIb. We are primarily concerned in determining dosage requirements during Phase IIa clinical trials. To examine dosage and appropriate frequency of doses, a group of patients is given the medicine in varied quantities.Phase IIb studies are designed to evaluate a drug's efficacy and determine how effective it is in terms of treating, preventing, and detecting a disorder. Our early product development team conducts Phase 2 clinical studies with the speed and finesse of medicine professionals, backed by a scientific, regulatory, and clinical organisation.
Late Phase Services
Phase II-III:
At every phase, there is however a passion for details.
Phase II and III clinical trials have numerous components. That's why we provide assistance on how to expedite clinical development's finer points. Our management teams assist avoid delays by guiding you through the whole regulatory process, from recruitment methods to medical writing and clinical logistics. No matter where your studies take place, our clinical solutions keep you connected at every level. We also save time by working with patient communities to find volunteers who are the ideal fit. We're here to help you remain on top of your studies, no matter how complicated they are.
Developing a plan for a quicker and easier Phase II-III
So far, your clinical development has showed a lot of promise, and you're getting closer to placing your product on the market. As you progress through Phases IIb and III, further scrutiny of your budding product will undoubtedly present new obstacles.This is when partnering with us pays off the most, as our experienced consultants dive deeper into their extensive knowledge and deploy the resources that best suit your needs – sharp strategies to keep things on track, clinical logistics to get trials up and running quickly, and regulatory knowledge to minimise obstacles that could result in additional risks, delays, and costs. Because our Regulatory & Access professionals understand clinical development, their technical insights - regulatory, pricing and reimbursement, and patient access – are targeted toward more practical, actionable solutions that can be implemented into your Med Pharma CRO development processes. It's the distinction between nice-to-have concepts in theory and concepts that work in practise. Whatever this stage throws at you, we'll be there to support you, just as involved in and excited about your prospective new treatment as you are.
Phase III-IV:
Taking you all the way to the finish line.
We're committed to getting the details just right as we guide you through the last push to commercialization. Med Pharma CRO's experts take great care to personalise scientific, strategic, and market solutions to your specific situations and people. With our infrastructure, multi-disciplinary experience, and the finest in organizational competencies, we provide a solid network for your Phase III and IV operations. When it's time to bring your novel therapy to market, we'll be there to establish a market strategy that will swiftly grow value – all while keeping a careful eye on long-term impacts and safety. We are pleased to offer: staff dedicated to project management with experience in the late stages; presence on the market to personalise solutions; to control expenses, a focused site management and monitoring capacity; data flow, trial administration, and reporting are all aided by integrated knowhow.
Overcoming the market access stumbling obstacle.
As your drug moves from testing to commercialization, late phase clinical studies are an exciting stage of clinical development. Marketing approval is in the works, and we're here to help you connect the dots and keep the momentum going. Regulators, payers, physicians, and patients are among the stakeholders who must be convinced that your drug or device is safe, effective, and provides greater value or benefit than the current standard of care. An elite team of consultants from Med Pharma CRO's Regulatory & Access consulting organisation helps clients chart the best, most efficient path through global regulatory, market access, and commercial hurdles. We've combined regulatory and market access expertise to deliver disruptive innovation to clients seeking a competitive edge at every stage of their development programmes. Our Regulatory & Access consulting firm shares cutting-edge thinking as well as practical, actionable advice. Our consultants know exactly how to interpret the guidance today to give you a strategic advantage because they wrote it yesterday. The experts at Med Pharma CRO assist companies in exploring the impact of a therapy and/or disease in a real-world setting and generating real-world data to support their proposition to regulators, payers, physicians, and patients. We recognise the importance of interconnected, patient-specific data that is longitudinal in order to track outcomes over time, and we are assisting a number of companies in overcoming this challenge, including through the use of prototype prospective/retrospective real-world evidence studies.
Post Launch:
Uncovering the true worth of your product.
Your perseverance has paid off and you've introduced a new medication that will benefit patients all over the world. However, in order for your product to reach its full potential, you'll need to keep track of ongoing clinical and safety data, as well as possibly generate real-world evidence to back up value-based pricing agreements. You'll have to manage regulatory compliance, raise product awareness, and encourage health professionals to recommend your product. In a nutshell, you'll need multi-stranded marketing that's compatible. Allow yourself to relax. We've thought of everything. We see the big picture of what stakeholders need by bringing together our regulatory, compliance, market access, and medical communications experts. This enables us to guide you through the product lifecycle while also providing evidence generation services and a real-world evidence strategy to back up your product positioning. We're here to assist you in gaining and maintaining patient access in your targeted market.
Data Operations (Clinical Data Management & Bio-statistical Management)
Using data to its full potential.
Our data processing crew is ready to help you make the most of the data you've worked so hard to gather by improving performance, lowering production costs, and anticipating risks. Our Data Processing team can offer: Clinical Data Management; Statistical Programming; Biostatistics.
The progression in clinical advancement
Designing Adaptive Trials: Adaptive trial designs make everyone's experience safer and more successful. We will help you adapt in real time based on the accumulating data if you check in with interim analyses on a regular basis.
Collection of Clinical Metadata: The way we collect patient data is evolving in a positive way. It may be difficult to compare data from sensors, wearables, recorded results, and other sources to the same set of standards. With a complete suite of resources in one place, our collection of clinical metadata connects the dots between data measurement, management, and analysis.
Medical Writing Solutions
To produce a profitable drug, you must have excellent writing skills.
Effective drug development programme necessitates high-quality medical writing. Pharmaceutical and biotech firms require a reliable, flexible, and experienced partner who can not only produce these documents but also function as a strategic partner and resolve critical challenges. The team is also experienced and skilled in defining and prioritizing which reports are required to comply with the Medical Regulations and a multitude of other regulatory guidelines. Our Medical Writing Solutions team works as a flexible partner to generate accurate messaging for a variety of clients. We go into the specifics to produce everything with full regulatory compliance, whether it is designing protocols and informed consent forms or a new drug filing. Our writers can smoothly build on (or entirely develop) your scientific, technical, medical, regulatory, and commercialization communications using our flexible outsourcing solutions. Med Pharma CRO has established a unique technique and created a team of writers who are professionals in their sector with over 20 years of writing and document support expertise. Med Pharma CRO provides a complete sourcing capability for all of our clients' medical writing needs, with flexible and scalable solutions and experience across the whole drug development life cycle.
Clinical Trial Logistics & Supply
Providing the necessary stuffs to the right people is crucial.
The finer points of a study's day-to-day operations can make or break its success. That's why our Clinical Trial Procurement and Logistical support team works tirelessly to ensure that the appropriate supplies arrive at the right time for the right individuals. We tackle logistical difficulties before they become a problem, regardless of their complexity or location.
